Physician profile
Moshe Ephrat
NPI 1134109879
$249,842.03
in general payments reported to CMS, 2019-2025
37 companies · $33K in 2025
The $33K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,841 · 2020: $24K · 2021: $26K · 2022: $57K · 2023: $52K · 2024: $50K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $108K · Food and Beverage: $13K · Travel and Lodging: $9,336 · Consulting Fee: $5,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $107,695.11 |
| Food and Beverage | $13,088.59 |
| Travel and Lodging | $9,336.48 |
| Consulting Fee | $5,175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $92,492.35 | 2020-2025 | Dupixent |
| Genzyme Corporation | $44,296.44 | 2019-2025 | |
| Optinose US, INC. | $39,708.46 | 2019-2025 | |
| Glaxosmithkline, LLC. | $37,424.77 | 2021-2025 | Nucala |
| Aerin Medical INC. | $18,609.18 | 2019-2025 | |
| Genentech USA, INC. | $5,575.55 | 2020 | |
| Intersect Ent, INC. | $4,348.87 | 2019-2021 | |
| Medtronic, INC. | $4,268.73 | 2024-2025 | Propel |
| Stryker Corporation | $547.57 | 2019-2025 | Xpress Ent Dilation System, Scopis Ent, Xerogel Nasal/Epistaxis 2 Pack |
| Neurent Medical Limited | $346.95 | 2022-2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $289.91 | 2023-2025 | Inspire |
| Hikma Pharmaceuticals USA | $261.07 | 2022-2025 | Ryaltris |
| Grifols USA, LLC | $233.56 | 2020-2025 | Xembify |
| Acclarent, INC | $223.78 | 2019-2023 | Trudi Nav Cable |
| Blueprint Medicines Corporation | $194.99 | 2023-2024 | Ayvakit |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moshe Ephrat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.